- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 26.44M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 27.8M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 30.68M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $7.62M |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Mar 31, 2025 | $6.64M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2025 | $11.92M |
| Capex | Q1 2025 · Mar 31, 2024 | $16.26M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | $28.57M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $25.8M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $50.5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $57.73M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $462.04M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $474.23M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $569.62M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $537.73M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $101.03M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $100.99M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $596.05M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $605.68M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $96.18M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $103.79M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.06B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.08B |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | $0.09 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.37 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | $0.09 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.46 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $54.14M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $59.99M |
| Net Income | Q1 2025 · Mar 31, 2025 | $2.5M |
| Net Income | Q1 2025 · Mar 31, 2024 | $41.96M |
| Operating Income | Q1 2025 · Mar 31, 2025 | $11.07M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $80.14M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $11.71M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $17.61M |